Documents
Application Sponsors
NDA 209376 | AMERICAN REGENT INC | |
Marketing Status
Prescription | 001 |
Prescription | 002 |
Prescription | 003 |
Application Products
001 | INJECTABLE;INJECTION | 1ML | 2 | TRALEMENT | TRACE ELEMENTS |
002 | SOLUTION;INTRAVENOUS | (5ML) EQ 0.3MG COPPER/ML;EQ 55MCG BASE/ML;EQ 60MCG BASE/ML;EQ 3MG BASE/ML | 1 | TRALEMENT | CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE |
003 | SOLUTION;INTRAVENOUS | (1ML) EQ 0.06MG COPPER/ML;EQ 3MCG BASE/ML;EQ 6MCG BASE/ML;EQ 1MG BASE/ML | 1 | TRALEMENT | CUPRIC SULFATE; MANGANESE SULFATE; SELENIOUS ACID; ZINC SULFATE |
FDA Submissions
TYPE 4; Type 4 - New Combination | ORIG | 1 | AP | 2020-07-02 | STANDARD |
MANUF (CMC); Manufacturing (CMC) | SUPPL | 2 | AP | 2021-06-30 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
AMERICAN REGENT INC
cder:Array
(
[0] => Array
(
[ApplNo] => 209376
[companyName] => AMERICAN REGENT INC
[docInserts] => ["",""]
[products] => [{"drugName":"TRALEMENT","activeIngredients":"TRACE ELEMENTS","strength":"1ML","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"None","rld":"TBD","rs":"No"}]
[labels] => [{"actionDate":"07\/02\/2020","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209376s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"07\/02\/2020","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Type 4 - New Combination","reviewPriority":"STANDARD","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2020\\\/209376s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2020\\\/209376Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2020-07-02
)
)